{"id":172344,"date":"2015-01-06T14:57:23","date_gmt":"2015-01-06T19:57:23","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/pioneering-method-developed-to-define-stages-of-stem-cell-reprogramming.php"},"modified":"2015-01-06T14:57:23","modified_gmt":"2015-01-06T19:57:23","slug":"pioneering-method-developed-to-define-stages-of-stem-cell-reprogramming","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/pioneering-method-developed-to-define-stages-of-stem-cell-reprogramming.php","title":{"rendered":"Pioneering method developed to define stages of stem cell reprogramming"},"content":{"rendered":"<p><p>  In a groundbreaking study that provides scientists with a  critical new understanding of stem cell development and its role  in disease, UCLA researchers at the Eli and Edythe Broad Center  of Regenerative Medicine and Stem Cell Research led by Dr.  Kathrin Plath, professor of biological chemistry, have  established a first-of-its-kind methodology that defines the  unique stages by which specialized cells are reprogrammed into  stem cells that resemble those found in the embryo.<\/p>\n<p>    The study was published online ahead of print in the journal    Cell.  <\/p>\n<p>    Induced pluripotent stem cells (known as iPSCs) are similar to    human embryonic stem cells in that both cell types have the    unique ability to self-renew and have the flexibility to become    any cell in the human body. iPSC cells, however, are generated    by reprogramming skin or blood cells and do not require an    embryo.  <\/p>\n<p>    Reprogramming is a long process (about one to two weeks) and    largely inefficient, with typically less than one percent of    the primary skin or blood cells successfully completing the    journey to becoming an iPSC. The exact stages a cell goes    through during the reprogramming process are also not well    understood. This knowledge is important, as iPSCs hold great    promise in the field of regenerative medicine, as they can    provide a single source of patient-specific cells to replace    those lost to injury or disease. They can also be used to    create novel disease models from which new drugs and therapies    can be developed.  <\/p>\n<p>    \"This research has broad impact, because by deepening our    understanding of cell reprogramming we have the potential to    improve disease modeling and the generation of better sources    of patient-specific specialized cells suitable for replacement    therapy,\" said Plath. \"This can ultimately benefit patients    with new and better treatments for a wide range of diseases.  <\/p>\n<p>    Drs. Vincent Pasque and Jason Tchieu, postdoctoral fellows in    the lab of Dr. Plath and co-first authors of the study,    developed a roadmap of the reprogramming process using detailed    time-course analyses. They induced the reprogramming of skin    cells into iPSC, then observed and analyzed on a daily basis or    every other day the process of transformation at the    single-cell level. The data were collected and recorded over a    period of up to two weeks.  <\/p>\n<p>    Plath's team found that the changes that happen in cells during    reprogramming occur in a sequential stage-by-stage manner, and    that importantly, the stages were the same across all the    different reprogramming systems and different cell types    analyzed.  <\/p>\n<p>    \"The exact stage of reprogramming of any cell can now be    determined,\" said Pasque. \"This study signals a big change in    thinking, because it provides simple and efficient tools for    scientists to study stem cell creation in a stage-by-stage    manner. Most studies to date ignore the stages of    reprogramming, but we can now seek to better understand the    entire process on both a macro and micro level.\"  <\/p>\n<p>    Plath's team further discovered that the stages of    reprogramming to iPSC are different from what was expected.    They found that it is not simply the reversed sequence of    stages of embryo development. Some steps are reversed in the    expected order; others do not actually happen in the exact    reverse order and resist a change until late during    reprogramming to iPSCs.  <\/p>\n<p>    \"This reflects how cells do not like to change from one    specialized cell type to another and resist a change in cell    identity,\" said Pasque. \"Resistance to reprogramming also helps    to explain why reprogramming takes place only in a very small    proportion of the starting cells.\"  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Go here to read the rest:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.sciencedaily.com\/releases\/2015\/01\/150105142118.htm\/RK=0\/RS=EtrHXfdpyOdKxC3OO6tdJC_wI_c-\" title=\"Pioneering method developed to define stages of stem cell reprogramming\">Pioneering method developed to define stages of stem cell reprogramming<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> In a groundbreaking study that provides scientists with a critical new understanding of stem cell development and its role in disease, UCLA researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research led by Dr. Kathrin Plath, professor of biological chemistry, have established a first-of-its-kind methodology that defines the unique stages by which specialized cells are reprogrammed into stem cells that resemble those found in the embryo. The study was published online ahead of print in the journal Cell <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/pioneering-method-developed-to-define-stages-of-stem-cell-reprogramming.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25],"tags":[],"class_list":["post-172344","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/172344"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=172344"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/172344\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=172344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=172344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=172344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}